Senator Young Questions RFK Jr. on Long Covid Therapeutics Development

Long Covid Challenge and Impact

• 🌍 Over 20 million Americans and 400 million people worldwide suffer from Long Covid, impacting workforce participation and costing $1 trillion annually, approximately 1% of global GDP.
• 💡 Senator Young emphasizes the urgent need for therapeutics and faster development of clinical trials to address this serious condition.

Current Approaches to Therapeutics

• 🔬 A previous Long Covid project at NIH, despite significant funding, yielded no results, prompting a shift to a new approach.
• 🤝 The new strategy involves launching a Long Covid consortium to bring together leading doctors and identify successful treatment protocols, learning from past crises like HIV and Covid-19.
• ⚠️ There's a concern that ivory tower science has historically ignored on-the-ground practitioners, a pattern they aim to break.

Accelerating Therapeutic Development

• ⏳ It typically takes 18 years for proven medical interventions to reach clinical practice, a timeline considered too long for Long Covid patients.
• 💊 The proposed solution involves exploring off-the-shelf approved drugs for repurposing, a strategy that has faced barriers from major pharmaceutical companies.
• 🌍 Senator Young suggests exploring research partnerships with other countries and considering agencies like ARPA-H, which may have more practical and faster research protocols than NIH.

Broader Government and Health Initiatives

• 🏠 The discussion touches upon the president's leadership in addressing homelessness and mental health challenges through civil commitment.
• ❄️ There's a consideration for a more assertive government role in providing care for individuals with serious mental illness, especially in extreme conditions, to prevent them from suffering or dying.